Abnormal cervical cytology: new names, familiar smears.
OBJECTIVE
To discuss the newest 2001 changes in The Bethesda System of cervical cytology classification and management guidelines for abnormal Pap smears.


METHODS
Extensive review of scientific literature and consensus guidelines.


CONCLUSIONS
Decision making about abnormal cervical cytology can be frustrating and controversial. It is imperative that nurse practitioners understand and practice the appropriate management protocol for cytological abnormalities.


CONCLUSIONS
Alarmingly, many providers are unsure of management guidelines for abnormal cervical cytology. The information in this article offers providers a clear protocol for cervical cytology classification to facilitate the confident management of abnormal Pap smears.
Carulli
Denise Trower
DT
Intensive Care Unit, University Community Hospital, Tampa, Florida, USA.
D005260:Female; D006801:Humans; D065006:Papanicolaou Test; D009626:Terminology as Topic; D002583:Uterine Cervical Neoplasms / Q000145:classification / Q000175:diagnosis*; D014626:Vaginal Smears / Q000145:classification*